{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:57:53Z","timestamp":1778003873827,"version":"3.51.4"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"name":"Department of Veterans Affairs, Veterans Health Administration","award":["V1CDA2022-68"],"award-info":[{"award-number":["V1CDA2022-68"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R03-NS091864"],"award-info":[{"award-number":["R03-NS091864"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Distinct genetic alterations determine glioma aggressiveness, however, the diversity of somatic mutations contributing to peritumoral hyperexcitability and seizures over the course of the disease is uncertain. This study aimed to identify tumor somatic mutation profiles associated with clinically significant hyperexcitability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single center cohort of adults with WHO grades 1\u20134 glioma and targeted exome sequencing (n\u2005=\u20051716) was analyzed and cross-referenced with a validated EEG database to identify the subset of individuals who underwent continuous EEG monitoring (n\u2005=\u2005206). Hyperexcitability was defined by the presence of lateralized periodic discharges and\/or electrographic seizures. Cross-validated discriminant analysis models trained exclusively on recurrent somatic mutations were used to identify variants associated with hyperexcitability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The distribution of WHO grades and tumor mutational burdens were similar between patients with and without hyperexcitability. Discriminant analysis models classified the presence or absence of EEG hyperexcitability with an overall accuracy of 70.9%, regardless of IDH1 R132H inclusion. Predictive variants included nonsense mutations in ATRX and TP53, indel mutations in RBBP8 and CREBBP, and nonsynonymous missense mutations with predicted damaging consequences in EGFR, KRAS, PIK3CA, TP53, and USP28. This profile improved estimates of hyperexcitability in a multivariate analysis controlling for age, sex, tumor location, integrated pathologic diagnosis, recurrence status, and preoperative epilepsy. Predicted somatic mutation variants were over-represented in patients with hyperexcitability compared to individuals without hyperexcitability and those who did not undergo continuous EEG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings implicate diverse glioma somatic mutations in cancer genes associated with peritumoral hyperexcitability. Tumor genetic profiling may facilitate glioma-related epilepsy prognostication and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noad176","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:18:27Z","timestamp":1694625507000},"page":"323-334","source":"Crossref","is-referenced-by-count":23,"title":["Glioma genetic profiles associated with electrophysiologic hyperexcitability"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-8398","authenticated-orcid":false,"given":"Steven","family":"Tobochnik","sequence":"first","affiliation":[{"name":"Department of Neurology, VA Boston Healthcare System , Boston, Massachusetts , USA"},{"name":"Department of Neurology, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Kristina C","family":"Dorotan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hia S","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Lapinskas","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayne","family":"Vogelzang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dana-Farber Cancer Institute , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Reardon","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith L","family":"Ligon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dana-Farber Cancer Institute , Boston, Massachusetts , USA"},{"name":"Department of Pathology, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenya Linda","family":"Bi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stelios M","family":"Smirnakis","sequence":"additional","affiliation":[{"name":"Department of Neurology, VA Boston Healthcare System , Boston, Massachusetts , USA"},{"name":"Department of Neurology, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"4","key":"2024020218204994800_CIT0001","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.10712","article-title":"Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life","volume":"54","author":"Klein","year":"2003","journal-title":"Ann Neurol."},{"issue":"5","key":"2024020218204994800_CIT0002","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol."},{"issue":"4","key":"2024020218204994800_CIT0003","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2016.26","article-title":"Seizures and gliomas","volume":"12","author":"Huberfeld","year":"2016","journal-title":"Nat Rev Neurol."},{"issue":"1","key":"2024020218204994800_CIT0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(97)00374-2","article-title":"Prevalence and prognostic significance of epilepsy in patients with gliomas","volume":"34","author":"Lote","year":"1998","journal-title":"Eur J Cancer"},{"issue":"26","key":"2024020218204994800_CIT0005","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"N Engl J Med."},{"issue":"8","key":"2024020218204994800_CIT0006","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"1","key":"2024020218204994800_CIT0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncr.33918","article-title":"Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system","volume":"128","author":"Gritsch","year":"2022","journal-title":"Cancer."},{"issue":"7775","key":"2024020218204994800_CIT0008","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature."},{"issue":"7775","key":"2024020218204994800_CIT0009","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature."},{"issue":"2","key":"2024020218204994800_CIT0010","doi-asserted-by":"crossref","first-page":"107500","DOI":"10.1016\/j.celrep.2020.03.064","article-title":"Glioma-induced alterations in neuronal activity and neurovascular coupling during disease progression","volume":"31","author":"Montgomery","year":"2020","journal-title":"Cell Rep"},{"issue":"5","key":"2024020218204994800_CIT0011","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.neuron.2023.01.013","article-title":"Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation","volume":"111","author":"Curry","year":"2023","journal-title":"Neuron."},{"issue":"1","key":"2024020218204994800_CIT0012","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/s41467-018-07113-0","article-title":"Perineuronal nets decrease membrane capacitance of peritumoral fast spiking interneurons in a model of epilepsy","volume":"9","author":"Tewari","year":"2018","journal-title":"Nat Commun."},{"issue":"2","key":"2024020218204994800_CIT0013","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3171\/2011.3.JNS1153","article-title":"Predictors of seizure freedom after resection of supratentorial low-grade gliomas: a review","volume":"115","author":"Englot","year":"2011","journal-title":"J Neurosurg."},{"issue":"9","key":"2024020218204994800_CIT0014","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/neuonc\/noac003","article-title":"IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation","volume":"24","author":"Mortazavi","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"7793","key":"2024020218204994800_CIT0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-020-1952-2","article-title":"PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis","volume":"578","author":"Yu","year":"2020","journal-title":"Nature."},{"key":"2024020218204994800_CIT0016","doi-asserted-by":"crossref","first-page":"106681","DOI":"10.1016\/j.eplepsyres.2021.106681","article-title":"Effect of PIK3CA variants on glioma-related epilepsy and response to treatment","volume":"175","author":"Tobochnik","year":"2021","journal-title":"Epilepsy Res."},{"issue":"4","key":"2024020218204994800_CIT0017","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell."},{"issue":"19","key":"2024020218204994800_CIT0018","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/WNL.0000000000003911","article-title":"Mutant IDH1 and seizures in patients with glioma","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology."},{"issue":"11","key":"2024020218204994800_CIT0019","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-018-0172-x","article-title":"BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors","volume":"24","author":"Koh","year":"2018","journal-title":"Nat Med."},{"key":"2024020218204994800_CIT0020","doi-asserted-by":"crossref","first-page":"692751","DOI":"10.3389\/fneur.2021.692751","article-title":"Correlation between tumor molecular markers and perioperative epilepsy in patients with glioma: a systematic review and meta-analysis","volume":"12","author":"Song","year":"2021","journal-title":"Front Neurol."},{"issue":"1","key":"2024020218204994800_CIT0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/nop\/npaa054","article-title":"Predictors of early, recurrent, and intractable seizures in low-grade glioma","volume":"8","author":"Jo","year":"2021","journal-title":"Neuro-Oncol Pract"},{"issue":"2","key":"2024020218204994800_CIT0022","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/cancers12020397","article-title":"Predictors of postoperative seizure outcome in low grade glioma: from volumetric analysis to molecular stratification","volume":"12","author":"Ius","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"2024020218204994800_CIT0023","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of oncopanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med."},{"issue":"19","key":"2024020218204994800_CIT0024","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"2024020218204994800_CIT0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atg.2015.08.005","article-title":"OncDRS: an integrative clinical and genomic data platform for enabling translational research and precision medicine","volume":"6","author":"Orechia","year":"2015","journal-title":"Appl Transl Genomics"},{"issue":"2","key":"2024020218204994800_CIT0026","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/WNP.0000000000000230","article-title":"Development and feasibility testing of a critical care eeg monitoring database for standardized clinical reporting and multicenter collaborative research","volume":"33","author":"Lee","year":"2016","journal-title":"J Clin Neurophysiol."},{"issue":"1","key":"2024020218204994800_CIT0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","article-title":"American clinical neurophysiology society\u2019s standardized critical care EEG terminology: 2021 version","volume":"38","author":"Hirsch","year":"2021","journal-title":"J Clin Neurophysiol."},{"issue":"7804","key":"2024020218204994800_CIT0028","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","article-title":"Mechanisms and therapeutic implications of hypermutation in gliomas","volume":"580","author":"Touat","year":"2020","journal-title":"Nature."},{"issue":"405","key":"2024020218204994800_CIT0029","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/01621459.1989.10478752","article-title":"Regularized Discriminant Analysis","volume":"84","author":"Friedman","year":"1989","journal-title":"J Am Stat Assoc."},{"issue":"1","key":"2024020218204994800_CIT0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/biostatistics\/kxj035","article-title":"Regularized linear discriminant analysis and its application in microarrays","volume":"8","author":"Guo","year":"2007","journal-title":"Biostatistics"},{"issue":"4","key":"2024020218204994800_CIT0031","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/cem.676","article-title":"Understanding the collinearity problem in regression and discriminant analysis","volume":"15","author":"N\u00e6s","year":"2001","journal-title":"J Chemom."},{"key":"2024020218204994800_CIT0032","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf."},{"issue":"4","key":"2024020218204994800_CIT0033","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods."},{"issue":"13","key":"2024020218204994800_CIT0034","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"2024020218204994800_CIT0035","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","article-title":"Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies","volume":"24","author":"Dong","year":"2015","journal-title":"Hum Mol Genet."},{"issue":"1","key":"2024020218204994800_CIT0036","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22225","article-title":"Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models","volume":"34","author":"Shihab","year":"2013","journal-title":"Hum Mutat."},{"issue":"16","key":"2024020218204994800_CIT0037","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"2024020218204994800_CIT0038","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"2024020218204994800_CIT0039","doi-asserted-by":"crossref","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","article-title":"The gene ontology resource: enriching a GOld mine","volume":"49","author":"Gene Ontology Consortium","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2024020218204994800_CIT0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet."},{"issue":"1","key":"2024020218204994800_CIT0041","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-022-04059-8","article-title":"Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma","volume":"159","author":"Tobochnik","year":"2022","journal-title":"J Neurooncol."},{"issue":"23","key":"2024020218204994800_CIT0042","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","article-title":"The coordinate regulation of the p53 and mTOR pathways in cells","volume":"102","author":"Feng","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"issue":"2","key":"2024020218204994800_CIT0043","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00001756-199601310-00028","article-title":"Nuclear accumulation of p53 protein following kainic acid-induced seizures","volume":"7","author":"Sakhi","year":"1996","journal-title":"Neuroreport."},{"key":"2024020218204994800_CIT0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2016.12.013","article-title":"Epileptic features and survival in glioblastomas presenting with seizures","volume":"130","author":"Toledo","year":"2017","journal-title":"Epilepsy Res."},{"issue":"10","key":"2024020218204994800_CIT0045","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/cddis.2010.55","article-title":"Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus","volume":"1","author":"Engel","year":"2010","journal-title":"Cell Death Dis."},{"issue":"7","key":"2024020218204994800_CIT0046","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(14)70040-7","article-title":"Malformations of cortical development: clinical features and genetic causes","volume":"13","author":"Guerrini","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"2024020218204994800_CIT0047","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bpa.12081","article-title":"BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors","volume":"24","author":"Prabowo","year":"2013","journal-title":"Brain Pathol."},{"issue":"12","key":"2024020218204994800_CIT0048","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/jnen\/nlz101","article-title":"Genomic analysis of dysembryoplastic neuroepithelial tumor spectrum reveals a diversity of molecular alterations dysregulating the MAPK and PI3K\/mTOR pathways","volume":"78","author":"Surrey","year":"2019","journal-title":"J Neuropathol Exp Neurol."},{"issue":"2","key":"2024020218204994800_CIT0049","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41588-022-01276-9","article-title":"Comprehensive multi-omic profiling of somatic mutations in malformations of cortical development","volume":"55","author":"Chung","year":"2023","journal-title":"Nat Genet."},{"issue":"8","key":"2024020218204994800_CIT0050","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/brain\/awac117","article-title":"Somatic variants in diverse genes leads to a spectrum of focal cortical malformations","volume":"145","author":"Lai","year":"2022","journal-title":"Brain."},{"issue":"2","key":"2024020218204994800_CIT0051","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jnen\/nlaa137","article-title":"Somatic focal copy number gains of noncoding regions of receptor tyrosine kinase genes in treatment-resistant epilepsy","volume":"80","author":"Vasudevaraja","year":"2021","journal-title":"J Neuropathol Exp Neurol."},{"issue":"4","key":"2024020218204994800_CIT0052","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ajmg.a.38626","article-title":"Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein","volume":"176","author":"Menke","year":"2018","journal-title":"Am J Med Genet A."},{"key":"2024020218204994800_CIT0053","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejpn.2022.08.002","article-title":"Electroencephalographic findings in ATRX syndrome: A new case series and review of literature","volume":"40","author":"Aiello","year":"2022","journal-title":"Eur J Paediatr Neurol."},{"issue":"8","key":"2024020218204994800_CIT0054","doi-asserted-by":"crossref","first-page":"e6574","DOI":"10.1371\/journal.pone.0006574","article-title":"Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions","volume":"4","author":"Daoud","year":"2008","journal-title":"PLoS One."},{"issue":"7","key":"2024020218204994800_CIT0055","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1007\/s00415-022-11040-y","article-title":"Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis","volume":"269","author":"Pascual-Morena","year":"2022","journal-title":"J Neurol."},{"issue":"3","key":"2024020218204994800_CIT0056","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1073\/pnas.1320611111","article-title":"Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity","volume":"112","author":"Meyer","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6190","key":"2024020218204994800_CIT0057","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad176\/52057725\/noad176.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/2\/323\/56549394\/noad176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/2\/323\/56549394\/noad176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T13:27:25Z","timestamp":1706880445000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/26\/2\/323\/7274875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,9,15]]},"published-print":{"date-parts":[[2024,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad176","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.22.23285841","asserted-by":"object"}]},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,1]]},"published":{"date-parts":[[2023,9,15]]}}}